Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
5Activity
0 of .
Results for:
No results containing your search query
P. 1
ISHRS - GNaughton - HSC Clinical Update

ISHRS - GNaughton - HSC Clinical Update

Ratings: (0)|Views: 1,617 |Likes:
Published by Erin Aguilar

More info:

Published by: Erin Aguilar on Nov 01, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

11/03/2012

pdf

text

original

 
Scalp Injection of Active Embryonic-like Cell-secreted Proteins and Growth Factors
Gail K. Naughton, Ph.D
.
1
 
2
DISCLOSURES:
 
Speaker has disclosed conflict of interest. Dr. Gail K. Naughtonserves as CEO and Chairman of the Board for Histogen, Inc.
 
Conflict of Interest
 
Technology Focus:
Regeneration 
Bioactive human growth factors
VEGF KGFFollistatin Stem Cell Factor
Human matrix components
Collagens LamininGAG DecorinFibronectin C-propeptide
Histogen’s technology focuses on stimulating a patient’s own stemcells by delivering a proprietary complex of human proteins thathave been shown to support stem cell growth and differentiation.
This
multipotent cell conditioned media 
has a broad rangeof applications in both aesthetics and therapeutics:Current and near-term:
Skincare and Cosmetics
First therapeutic, no reimbursement:
Hair growth
Second therapeutic:
Oncology
Other Opportunities for soluble and insolubleextracellular matrix:
Wound care, Device Coating,Bone and Muscle regeneration, Dermal filler
3

Activity (5)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads
Emanuel Drumond liked this
William Strode liked this
Paul Smith liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->